OVERVIEW
Cytomegalovirus (CMV) infections are common in patients undergoing solid organ and hematopoietic stem cell transplantation. Test your knowledge and interact with faculty as they present multiple clinical cases on the management of CMV infection in patients undergoing transplantation. The faculty will discuss how to select appropriate therapy based on clinical presentation and disease and patient characteristics and present the most recent data supporting their rationale for treatment choices. [bold]You must be registered for the American Transplant Congress 2022 to attend this symposium.[/bold]
TARGET AUDIENCE
This activity is intended for transplant specialists (solid organ and hematopoietic stem cell transplants), infectious disease specialists, transplant pharmacists, advance practice providers (NPs/PAs), and other healthcare professionals interested in the management of CMV infection following transplantation.
GOAL STATEMENT
The goal of this activity is that learners will be better able to discuss the role of new treatments for CMV infection in patients following transplant and how to best incorporate them into clinical practice.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST][ITEM]Clinical burden of refractory or resistant CMV infection post-transplant[ITEM]Prevention of CMV infection post-transplant[/LIST]Have greater competence related to[LIST][ITEM]Management of CMV infection with conventional therapy and infections that are resistant to conventional antiviral therapy[/LIST]Demonstrate greater confidence in their ability to[LIST][ITEM]Select evidence-based, individualized management strategies for CMV in patients following transplant[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [italic]AMA PRA Category 1 Credits[/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for 1.0 contact hour(s) (0.100 CEUs) (Universal Activity Number: JA0007105-0000-22-127-L01-P).
Sheraton Hotel
39 Dalton St Republic Ballroom
Boston, Massachusetts, 02199
United States
This symposium is not part of the ATC official educational program and the sessions and content are not endorsed by ATC.
Supported by an independent educational grant from [bold]Takeda Pharmaceuticals U.S.A., Inc[/bold].